Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphoma | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

XML

Clinical/translational cancer immunotherapy

Original research

Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphoma

Online download statistics by month:

Online download statistics by month: February 2021 to December 2022

	Abstract	Full	Pdf
Feb 2021	557	557	103
Mar 2021	266	266	94
Apr 2021	165	165	59
May 2021	194	194	39
Jun 2021	164	163	52
Jul 2021	159	159	33
Aug 2021	162	162	41
Sep 2021	122	122	34
Oct 2021	123	123	42
Nov 2021	163	163	43
Dec 2021	131	131	33
Jan 2022	150	154	58
Feb 2022	102	107	54
Mar 2022	155	162	61
Apr 2022	125	127	51
May 2022	125	131	55
Jun 2022	101	105	33
Jul 2022	121	122	32
Aug 2022	119	119	27
Sep 2022	117	117	42
Oct 2022	118	118	39
Nov 2022	72	73	21
Dec 2022	90	90	25
Total	3601	3630	1071